HighTower Advisors
THC icon

HighTower Advisors’s Tenet Healthcare THC Stock Holding History

HighTower Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
10,295
-3,316
-24% -$610K ﹤0.01% 1804
2026
Q1 		$2.57M Buy
13,611
+2,633
+24% +$555K ﹤0.01% 1572
2025
Q4 		$2.18M Sell
10,978
-210
-2% -$42.4K ﹤0.01% 1620
2025
Q3 		$2.27M Buy
11,188
+971
+10% +$172K ﹤0.01% 1562
2025
Q2 		$1.8M Buy
10,217
+1,475
+17% +$222K ﹤0.01% 1626
2025
Q1 		$1.18M Buy
8,742
+2,132
+32% +$281K ﹤0.01% 1856
2024
Q4 		$834K Sell
6,610
-426
-6% -$63.3K ﹤0.01% 2093
2024
Q3 		$1.16M Buy
7,036
+758
+12% +$115K ﹤0.01% 1842
2024
Q2 		$834K Sell
6,278
-356
-5% -$42.9K ﹤0.01% 1955
2024
Q1 		$698K Buy
6,634
+1,729
+35% +$155K ﹤0.01% 2042
2023
Q4 		$366K Sell
4,905
-40,035
-89% -$2.54M ﹤0.01% 2564
2023
Q3 		$2.98M Buy
44,940
+19,099
+74% +$1.43M 0.01% 1161
2023
Q2 		$2.11M Buy
+25,841
New +$1.84M ﹤0.01% 1328
2022
Q2 		– Sell
-2,544
Closed -$219K – 3529
2022
Q1 		$219K Buy
+2,544
New +$209K ﹤0.01% 2769
2020
Q3 		– Sell
-148,060
Closed -$2.69M – 2696
2020
Q2 		$2.69M Sell
148,060
-6,005
-4% -$118K 0.01% 705
2020
Q1 		$2.2M Sell
154,065
-3,526
-2% -$101K 0.01% 719
2019
Q4 		$6.01M Sell
157,591
-1,989
-1% -$59.6K 0.04% 479
2019
Q3 		$3.52M Buy
159,580
+8,970
+6% +$191K 0.02% 696
2019
Q2 		$3.11M Buy
+150,610
New +$3.47M 0.02% 735
2016
Q2 		– Sell
-39,506
Closed -$1.14M – 2014
2016
Q1 		$1.14M Buy
39,506
+1,154
+3% +$30K ﹤0.01% 962
2015
Q4 		$1.16M Sell
38,352
-87,281
-69% -$2.86M 0.01% 885
2015
Q3 		$4.64M Sell
125,633
-1,251
-1% -$64.6K 0.06% 332
2015
Q2 		$7.35M Buy
126,884
+23,611
+23% +$1.21M 0.12% 181
2015
Q1 		$5.11M Sell
103,273
-3,802
-4% -$178K 0.08% 285
2014
Q4 		$5.42M Sell
107,075
-12,527
-10% -$655K 0.08% 260
2014
Q3 		$7.1M Buy
119,602
+13,297
+13% +$742K 0.12% 202
2014
Q2 		$4.99M Buy
+106,305
New +$4.8M 0.09% 260

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HighTower Advisors's THC Position: Q2 2026 in Review

HighTower Advisors reduced its Tenet Healthcare (THC) stake by 24% in Q2 2026, selling an estimated $610K and leaving 10,295 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1804.

HighTower Advisors first reported a position in THC in Q2 2014 and has held it in 27 quarters since. The position peaked at $7.35M in Q2 2015. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • HighTower Advisors held 10,295 shares of Tenet Healthcare worth $1.93M as of Q2 2026.
  • HighTower Advisors sold 3,316 Tenet Healthcare shares in Q2 2026, an estimated $610K.
  • Tenet Healthcare made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1804 holding.
  • HighTower Advisors first reported a position in Tenet Healthcare in Q2 2014 and has held it in 27 quarters since.
  • HighTower Advisors's Tenet Healthcare position peaked at $7.35M in Q2 2015.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.